Program
Join our sponsors for industry symposiums
Friday, February 2, 2024 - Saanich Room
12:30pm - 1:30pm Merck Symposium + Lunch
The Changing Landscape of HPV How to Protect Your Patients
Speaker: Dr. Angel Chu
Learning Objectives:
Outline the burden of HPV related disease and cancers in Canada
Discuss the latest clinical data and recommendations for HPV immunization
Discuss current immunization recommendations (National Advisory Committee on Immunization) and schedules
Describe opportunities to initiate discussions and counsel about HPV and HPV prevention
5:15pm - 6:15pm Sanofi Symposium + Reception
Is the Elephant in the Room? Tackling the unmet RSV disease burden in British Columbia’s pediatric population.
Speaker: Dr. Jennifer Balfour and Dr. Nirma Khatri Vadlamudi
Learning Objectives:
Review the impact of RSV disease in pediatric populations in British Columbia and lessons learned from a front-line clinician's perspective.
Appreciate current pediatric RSV disease epidemiology in BC and challenges surrounding the current Immunoprophylaxis program.
Explore solutions to address the persisting disease burden.
Saturday, February 3, 2024 - Saanich Room
7:15am - 8:15am Pfizer Symposium + Breakfast
New Respiratory Syncytial Virus (RSV) Vaccines: Lets Protect Infants and Older Adults
Speaker: Dr. George G. Zhanel
Learning Objectives:
Describe the need for respiratory syncytial virus (RSV) infection prevention in children and older adults
Discuss the clinical presentation, diagnosis, testing, and current standard of care for RSV infection
Review the new RSV vaccines available or in development in Canada
Discuss case studies of patients who should be considered for RSV vaccination
12:15pm - 1:15pm Paladin Symposium + Lunch
Management of Moderate to Severe MRSA Infection in Difficult to Engage Patients
Speaker: Dr. Daniel Smyth
Learning Objectives:
Explore the challenges of treating moderate to severe MRSA infection in difficult-to-engage patients
Review the pharmacology, indications, and advantages/disadvantages of oral and parenteral MRSA treatment options
Review strategies to facilitate discharge in the context of an overwhelmed healthcare system, including shorter course therapies, early IV to PO transition, and longer acting parenteral options